FINANCE MONTHLY CEO AWARDS 2014
EUROPE
a Vision
in the UK. The highly specialised plant, in Wolverhampton, puts the company in a strong position to compete on price as well as product performance.
And John is working on a global level, driving exports to Europe, Asia and Australasia, and more recently Scandinavia. His vision is to achieve global market leadership, with an eminently strong and expanding product range.
“I’m excited about the prospects for the company,” says John, “we’re working now on new products and applications for Fantex, and this is taking the company into new markets with true growth potential”.
What next for All in One Medical?
John is steering the company through a programme of broadening out the product range. By adding Fantex protective coatings to solids, liquids and gels, they’re able to explore new product ideas across a wide range of industry sectors.
This opens up a whole new world of possibilities where hygiene is an issue.
In the dairy industry, they are developing a hygienic wash for cows’ teats.
And talks are currently under way with a number of garment manufacturers. Applying Fantex to fabrics helps keep them clean, fresh
and odour free. Clothing retailers and workwear manufacturers are naturally very interested.
They’re also working on applications within the nursing and care homes industry, including the development of hygienic seat covers for wheelchairs.
The company wants to go deeper into the medical industry too. Its core values are about responding to the needs of people, and their protection from infection in a medical environment. This extends to healthcare professionals, patients and the general public.
John is currently engaged in recruiting additional management talent to see the business through its next phase of product and market expansion.
already offers huge scope for growth across the world.
Beringea Partner, Stephane Mery, who led the transaction commented: “I am thrilled with our investment, and to be supporting such a great team. I am also delighted that our investment is helping a British company bring its manufacturing back to the UK. DCCL’s highly
specialised plant in Wolverhampton allows the Company to successfully outperform Chinese manufacturers on both quality and price.”
And it doesn’t stop there. All in One Medical is pursuing a programme of pioneering research and cutting edge innovation right now, paving the way for rapid and massive growth.
With expansive plans afoot to grow export markets and push the boundaries of innovation, John needs a good team around him to deliver the next generation of Fantex products.
Whilst All in One Medical is in the enviable position of producing products that perform such an
Things are moving forward quickly, with the company applying for four new patents for Fantex in the last month. Fantex provides an excellent opportunity to improve the lives of people, to make a real difference – the essence of the company’s raison d’être. And with hospital-acquired infections being the 4th biggest killer in the US, it’s a very welcome breakthrough.
And financially? The company continues on its path of solid profit growth, delivering on the hopes and expectations of its stakeholders.
And what next for John Hawkins?
important, life-saving function with little competition, John is not complacent
“As CEO it’s my duty to ensure we continue to drive high standards, infallible product performance and impeccable customer service across our global territories. We need to educate our markets too, so they understand the far reaching benefits of using our products. There is a lot of work to be done, and I’m looking forward to it”.
l Website:
www.allinonemedical.com FINANCEMONTHLY 39
Page 1 |
Page 2 |
Page 3 |
Page 4 |
Page 5 |
Page 6 |
Page 7 |
Page 8 |
Page 9 |
Page 10 |
Page 11 |
Page 12 |
Page 13 |
Page 14 |
Page 15 |
Page 16 |
Page 17 |
Page 18 |
Page 19 |
Page 20 |
Page 21 |
Page 22 |
Page 23 |
Page 24 |
Page 25 |
Page 26 |
Page 27 |
Page 28 |
Page 29 |
Page 30 |
Page 31 |
Page 32 |
Page 33 |
Page 34 |
Page 35 |
Page 36 |
Page 37 |
Page 38 |
Page 39 |
Page 40 |
Page 41 |
Page 42 |
Page 43 |
Page 44 |
Page 45 |
Page 46 |
Page 47 |
Page 48 |
Page 49 |
Page 50 |
Page 51 |
Page 52 |
Page 53 |
Page 54 |
Page 55 |
Page 56 |
Page 57 |
Page 58 |
Page 59 |
Page 60 |
Page 61 |
Page 62 |
Page 63 |
Page 64 |
Page 65 |
Page 66 |
Page 67 |
Page 68 |
Page 69 |
Page 70 |
Page 71 |
Page 72 |
Page 73 |
Page 74 |
Page 75 |
Page 76 |
Page 77 |
Page 78 |
Page 79 |
Page 80 |
Page 81 |
Page 82 |
Page 83 |
Page 84 |
Page 85 |
Page 86